WHY GcMAF is working following the same pattern as in HIV infected patients?[/B]
WHY is this not studied further?
WHY is it known that XMRV is present in tissues, and yet, studies do not look in tissues, instead of in blood?
WHY dont we have a 100% replication study of the 2 positive studies?
WHY did they only test for 14 samples of the Science study, out of which only TWO were positive?
If XMRV or related MLVs are out there (I dont think this is questionable), WHY this study did not find even 1 positive? By chance, they shouldve.
I think they tested 14 samples from persons the WPI found positive and 2 of them were in Lomardi et al. It's better you check that again before believing me, but i think it was that way.
There are some questions that come to my mind right now.
Ila Singh had found XMRV in prostate cancer. What tests did she use there? Did she look in blood or only in prostate tissue? Sorry but i'm too tired and lazy to check by myself right now. She did not find any XMRV in the WPI's "positives" but i think she reported to correctly identify the positive controls. What type were those? Spiked samples?
If so, what could be really interesting, would be for her to test the blood of some of her XMRV+ prostate cancer cases. I'm no scientist, but i would like to see someone's assay correctly identify a clinical sample.
There seems to have been a new Switzer, CDC study
http://www.plosone.org/article/info:doi/10.1371/journal.pone.0019065#abstract0
and even though they say they don't find an association between XMRV and prostate cancer, they also say that they have found it and that it was not contamination.
So this would prove XMRV is a virus, not just false positives resulting from mouse material and that it's out there in the human population. Which would, for example, make Coffin's statement, that XMRV should be left behind, seem quite wierd and to me, even irresponsible.
If they say what they've found does not mean there's an association between prostate cancer and XMRV, then i think it can only mean that there's XMRV in the general population at that percentage. So that would mean the 0/0 studies are either wrong, were very unlucky in their cohort selection or XMRV does not occur everywhere.
Actually, to me, it seems like big news the CDC has found XMRV, even if i don't see a big reaction to it yet.
Unfortunately their study does not say anything about healthy controls.
What i'd like to see now, is Switzer using his blood assay from the negative ME/CFS studies on those XMRV+ prostate cancer cases. That would show what they are worth. So, i'm waiting...